Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 19 Dec 2017
At a glance
- Drugs Zoledronic acid (Primary) ; Clodronic acid; Demeclocycline; Ibandronic acid; Tetracycline
- Indications Breast cancer; Cancer metastases
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 13 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Sep 2017.
- 21 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Jun 2017.